Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Topical delivery of tofacitinib citrate loaded novel nanoemulgel for the management of 2,4-Dichlorodinitrobenzene induced atopic dermatitis in mice model
Srividya Atmakuri, Shweta Nene, Harsha Jain, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 80, pp. 104145-104145
Closed Access | Times Cited: 20

Showing 20 citing articles:

Recent Approaches for the Topical Treatment of Psoriasis Using Nanoparticles
Krisztina Bodnár, Pálma Fehér, Zoltán Ujhelyi, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 449-449
Open Access | Times Cited: 13
Investigating the efficacy of gliclazide encapsulated hydrogel in the preclinical mice model for atopic dermatitis
Kalpana Mamale, Shalini Shukla, Priyanka Mahale, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 1
A molecularly imprinted polymer-based electrochemical sensor for the determination of tofacitinib
Fatma Budak, Ahmet Çetinkaya, S. Irem Kaya, et al.
Microchimica Acta (2023) Vol. 190, Iss. 6
Closed Access | Times Cited: 16
High mobility group box 1 cytokine targeted topical delivery of resveratrol embedded nanoemulgel for the management of atopic dermatitis
Shweta Nene, Geetanjali Devabattula, Ganesh Vambhurkar, et al.
Drug Delivery and Translational Research (2024) Vol. 15, Iss. 1, pp. 134-157
Closed Access | Times Cited: 5
Nanocarrier-Integrated Microneedles: Divulging the Potential of Novel Frontiers for Fostering the Management of Skin Ailments
Pooja Khairnar, Vivek Phatale, Shalini Shukla, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 5, pp. 2118-2147
Closed Access | Times Cited: 5
Hansen Solubility Parameters, Computational, and Thermodynamic Models for Tofacitinib Citrate Solubility in Neat Mono Solvents, and GastroPlus Based Predicted In Vivo Performance of Subcutaneous Solution in Humans
Iman Ehsan, Mudassar Shahid, Subramanian Natesan, et al.
AAPS PharmSciTech (2025) Vol. 26, Iss. 3
Closed Access
Tofacitinib in focus: Fascinating voyage from conventional formulations to novel delivery systems
Priti Yadav, Sarika Wairkar
International Journal of Pharmaceutics (2025), pp. 125253-125253
Closed Access
Dermal Delivery of NanoFormulations: An Emerging Technology in Dermatological Conditions
Mohee Shukla, Satya Narain, Ashwani Kumar, et al.
BioNanoScience (2025) Vol. 15, Iss. 2
Closed Access
N-trimethyl chitosan and tripalmitin loaded solid lipid nanoparticles of tofacitinib citrate: Characterization and in-vivo anti-inflammatory assessment
Harekrishna Roy, Siva Prasad Panda, Sunil Kumar Panda, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104789-104789
Closed Access | Times Cited: 10
Tofacitinib in Dermatology: A Potential Opportunity For Topical Applicability Through Novel Drug-Delivery Systems
Akanksha Mahajan, Gajanand Sharma, Anil Thakur, et al.
Nanomedicine (2024) Vol. 19, Iss. 1, pp. 79-101
Closed Access | Times Cited: 2
Topical delivery of baricitinib-impregnated nanoemulgel: a promising platform for inhibition of JAK -STAT pathway for the effective management of atopic dermatitis
Shweta Nene, Geetanjali Devabattula, Ganesh Vambhurkar, et al.
Drug Delivery and Translational Research (2024)
Closed Access | Times Cited: 2
Transdermal delivery and exploration of preclinical anti-rheumatoid efficacy of pirfenidone embedded nanoemulgel in adjuvant-induced rat model
Rimsha Nooreen, Shweta Nene, Ganesh Vambhurkar, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 105428-105428
Closed Access | Times Cited: 1
A Review on Nanosystem-Based Delivery of Tofacitinib for Enhanced Treatment of Autoimmune Diseases and Inflammation
Thi‐Thao‐Linh Nguyen, Van‐An Duong
BioNanoScience (2024) Vol. 14, Iss. 2, pp. 2048-2064
Closed Access | Times Cited: 1
Evaluation of preclinical efficacy of apremilast-loaded liquid crystalline nanoparticulate gel in amelioration of atopic dermatitis
Shweta Nene, Ganesh Vambhurkar, Kamatham Pushpa Tryphena, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 96, pp. 105653-105653
Closed Access | Times Cited: 1
Versatility of emulgel in topical drug delivery transforming its expedition from bench to bedside.
Pragati Ramesh Kumbhar, Harita R. Desai, Vaibhavi Meghraj Desai, et al.
Expert Opinion on Drug Delivery (2024)
Closed Access | Times Cited: 1
Formulation development and in vivo evaluation of nanoemulgel containing Adhatoda vasaka (L.) Nees extract for wound healing activity
Nidhi Kumari, Juber Akhtar, Badruddeen Badruddeen, et al.
Annals of Phytomedicine An International Journal (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 2
Esterase responsive release of anti-cancer agents from conjugated lipid nanocarrier and the regulatory considerations
Priya Varpe, Ramesh Joga, Gayatri Aglave, et al.
Pharmaceutical Patent Analyst (2024) Vol. 13, Iss. 1-3, pp. 31-43
Closed Access
Contemplating Novel W/O Emulsion Based Gel for Anti-Psoriatic Activity of Tofacitinib in Imiquimod-Induced Balb/C Mice Model
Ashwini Aratwar, Indrani Maji, Shrilekha Chilvery, et al.
AAPS PharmSciTech (2024) Vol. 26, Iss. 1
Closed Access
Transethosome as a versatile nano vehicle for various indications and its regulatory insights
Ramesh Joga, Bharathi Kannan, Sravani Yerram, et al.
Pharmaceutical Development and Technology (2023) Vol. 28, Iss. 10, pp. 1056-1078
Closed Access | Times Cited: 1
Lipid-Based Mesoporous Silica Nanoparticles: A Paradigm Shift in Management of Pancreatic Cancer
Kiran Kumar Bellapu, Ramesh Joga, B Kannan, et al.
Pharmaceutical Patent Analyst (2023) Vol. 12, Iss. 6, pp. 261-273
Closed Access
Page 1

Scroll to top